| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.75.1.105 |
| P698 | PubMed publication ID | 8013068 |
| P2093 | author name string | J R Teerlink | |
| M A Pfeffer | |||
| J M Pfeffer | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ventricular remodeling | Q7920323 |
| P304 | page(s) | 105-113 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats | |
| P478 | volume | 75 |
| Q36342127 | A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway |
| Q59618930 | A single bout of exercise promotes sustained left ventricular function improvement after isoproterenol-induced injury in mice |
| Q41112375 | Acute Catecholamine Exposure Causes Reversible Myocyte Injury Without Cardiac Regeneration. |
| Q36513042 | Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells |
| Q43509334 | Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis |
| Q33768273 | Bidirectional regulation of angiogenesis and miR-18a expression by PNS in the mouse model of tumor complicated by myocardial ischemia |
| Q36771475 | Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. |
| Q47099413 | Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model |
| Q51186140 | Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. |
| Q42880557 | Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide |
| Q44207431 | Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle |
| Q43244733 | Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats |
| Q41682898 | Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes |
| Q88445700 | Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility |
| Q44237521 | Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver |
| Q44744175 | Does terbutaline damage the developing heart? |
| Q35976420 | Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR. |
| Q30357381 | Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure. |
| Q89782554 | Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies |
| Q37174597 | Early apoptosis in different models of cardiac hypertrophy induced by high renin-angiotensin system activity involves CaMKII. |
| Q46305105 | Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse isoproterenol-induced myocardial necrosis |
| Q37672852 | Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats. |
| Q28378192 | Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat |
| Q53155952 | Granulocyte colony-stimulating factor improves early remodeling in isoproterenol-induced cardiac injury in rats. |
| Q64062949 | Growth differentiation factor 11 is involved in isoproterenol‑induced heart failure |
| Q77996159 | Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits |
| Q73016844 | Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection |
| Q90365024 | Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury |
| Q42247798 | Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates |
| Q36656914 | Lack of cardioprotection by single-dose magnesium prophylaxis on isoprenaline-induced myocardial infarction in adult Wistar rats |
| Q85123480 | Lipotab, a polyherbal formulation, attenuates isoprenaline-induced left ventricular remodeling and heart failure in rats |
| Q37688764 | Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice |
| Q26827231 | Management of fibrosis: the mesenchymal stromal cells breakthrough |
| Q49685899 | Mesenchymal stem cells overexpressing adrenomedullin improve heart function through antifibrotic action in rats experiencing heart failure |
| Q36697674 | Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure |
| Q35170119 | Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis |
| Q38973209 | Neurohormonal activation in heart failure with reduced ejection fraction |
| Q46680855 | Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure |
| Q64930085 | Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats. |
| Q39463779 | Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers |
| Q43903293 | Protection by endogenous FGF-2 against isoproterenol-induced cardiac dysfunction is attenuated by cyclosporine A. |
| Q90108202 | Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis |
| Q37996857 | Rodent models of heart failure: an updated review. |
| Q24805251 | Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T |
| Q93054062 | Small animal models of heart failure |
| Q47875731 | Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes |
| Q80453584 | Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats |
| Q44650601 | Terbutaline Is a Developmental Neurotoxicant: Effects on Neuroproteins and Morphology in Cerebellum, Hippocampus, and Somatosensory Cortex |
| Q74141950 | Ventricular remodeling surgery for heart failure: small animals and how to measure an improvement in ventricular function |
| Q47097309 | Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine |
| Q92525303 | c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration |
| Q33828730 | β-Adrenergic receptor subtype signaling in heart: from bench to bedside |
Search more.